×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Medical Functions Contribution to Benefit-Risk Assessment
Session Chair(s)
Lisa Beth Ferstenberg, MD
Principal Patient Safety Physcian
AstraZenca, United States
Machine Learning, Artificial Intelligence and Blockchain are just some of the technologies finding applications in healthcare. In this session, we will focus on a few of the challenges and exciting advancements enabled by computer- based data management.
Learning Objective : (1) Understand opportunities for communicating risk to Patients and HCPs (2) Key aspects of effectiveness evaluation through digital (3) Limitations imposed by data privacy and pharmacovigilance guidance (GVP)
Speaker(s)
Challenges in Post-Marketing Benefit Risk Assessment
Simon Ingate, PhD, MBA
Axian Consulting Limited, United Kingdom
Engagement Manager
Blockchain in Clinical and Safety Data Management
Kate Gofman, MD, PhD
BioNTech US, United States
Senior Director, Safety Strategy Lead
Factbox For Benefit Risk Analysis
Frederic Bouder, PhD
University of Stavanger, Norway
Professor in Risk Management
A Mobile App for Assessing Patient Risk
Ravi Gopalakrishnan, MBA, MS
AstraZeneca, United States
Head of Digital Platform and Applications
Have an account?